26 related articles for article (PubMed ID: 38542814)
1. Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Huttasch M; Roden M; Kahl S
Metabolism; 2024 May; ():155937. PubMed ID: 38782182
[TBL] [Abstract][Full Text] [Related]
2. Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges.
Xie C; Alkhouri N; Elfeki MA
World J Hepatol; 2024 May; 16(5):731-750. PubMed ID: 38818288
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Open-Label Semaglutide on Metabolic Dysfunction-Associated Steatotic Liver Disease in People With HIV.
Lake JE; Kitch DW; Kantor A; Muthupillai R; Klingman KL; Vernon C; Belaunzaran-Zamudio PF; Fichtenbaum CJ; Heath S; Perazzo H; Corey K; Brown TT; Landay A; Sattler F; Erlandson KM
Ann Intern Med; 2024 Apr; ():. PubMed ID: 38684100
[No Abstract] [Full Text] [Related]
4. The MASLD criteria overlook a number of adolescent patients with severe steatosis.
Pan Z; Eslam M;
J Hepatol; 2024 Mar; ():. PubMed ID: 38556112
[No Abstract] [Full Text] [Related]
5. Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease.
Soto-Catalán M; Opazo-Ríos L; Quiceno H; Lázaro I; Moreno JA; Gómez-Guerrero C; Egido J; Mas-Fontao S
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474208
[TBL] [Abstract][Full Text] [Related]
6. GLP-1 and PYY for the treatment of obesity: a pilot study on the use of agonists and antagonists in diet-induced rats.
Oertel M; Ziegler CG; Kohlhaas M; Nickel A; Kloock S; Maack C; Sequeira V; Fassnacht M; Dischinger U
Endocr Connect; 2024 Mar; 13(3):. PubMed ID: 38300808
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of long acting GLP1R/GCGR agonist in a DIO and biopsy-confirmed mouse model of NASH suggest a beneficial role of GLP-1/glucagon agonism in NASH patients.
Monfeuga T; Norlin J; Bugge A; Gaalsgaard ED; Prada-Medina CA; Latta M; Veidal SS; Petersen PS; Feigh M; Holst D
Mol Metab; 2024 Jan; 79():101850. PubMed ID: 38065435
[TBL] [Abstract][Full Text] [Related]
8. Obese mice weight loss role on nonalcoholic fatty liver disease and endoplasmic reticulum stress treated by a GLP-1 receptor agonist.
Pontes-da-Silva RM; de Souza Marinho T; de Macedo Cardoso LE; Mandarim-de-Lacerda CA; Aguila MB
Int J Obes (Lond); 2022 Jan; 46(1):21-29. PubMed ID: 34465857
[TBL] [Abstract][Full Text] [Related]
9. Semaglutide Modulates Extracellular Matrix Production of LX-2 Cells via Exosomes and Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Scavo MP; Lisco G; Depalo N; Rizzi F; Volpe S; Arrè V; Carrieri L; Notarnicola M; De Nunzio V; Curri ML; De Pergola G; Piazzolla G; Giannelli G
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338770
[TBL] [Abstract][Full Text] [Related]
10. Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY
Kloock S; Haerting N; Herzog G; Oertel M; Geiger N; Geier A; Sequeira V; Nickel A; Kohlhaas M; Fassnacht M; Dischinger U
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542814
[TBL] [Abstract][Full Text] [Related]
11. Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments.
Yanai H; Adachi H; Hakoshima M; Iida S; Katsuyama H
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895151
[TBL] [Abstract][Full Text] [Related]
12. The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis.
Chandrasekaran P; Weiskirchen R
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256181
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
